NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 130 filers reported holding NUVATION BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,674,294 | -40.9% | 1,249,473 | -20.7% | 0.13% | -36.3% |
| Q2 2023 | $2,835,000 | -18.7% | 1,575,000 | -25.0% | 0.20% | -21.5% |
| Q1 2023 | $3,485,999 | -27.4% | 2,100,000 | -16.0% | 0.26% | -36.0% |
| Q4 2022 | $4,799,999 | -16.9% | 2,500,000 | -3.1% | 0.41% | -9.2% |
| Q3 2022 | $5,779,000 | +1.0% | 2,580,000 | +46.0% | 0.45% | +10.6% |
| Q2 2022 | $5,724,000 | -15.0% | 1,766,657 | +38.0% | 0.40% | +12.2% |
| Q1 2022 | $6,732,000 | +221.3% | 1,279,900 | +419.4% | 0.36% | +367.5% |
| Q4 2021 | $2,095,000 | -14.5% | 246,417 | 0.0% | 0.08% | -19.8% |
| Q3 2021 | $2,449,000 | +6.7% | 246,417 | 0.0% | 0.10% | +21.5% |
| Q2 2021 | $2,295,000 | -63.4% | 246,417 | -58.9% | 0.08% | -76.2% |
| Q1 2021 | $6,270,000 | – | 600,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |